Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Inks Agreement with Harvard Pilgrim for Access to Cancer Dx Services

NEW YORK (GenomeWeb) – Cancer Genetics today announced that it has signed an agreement with Harvard Pilgrim Healthcare to provide its cancer diagnostic services.

Harvard Pilgrim's provider network includes more than 135 hospitals and 28,000 doctors covering more than one million people in Massachusetts, Connecticut, and Maine. Cancer Genetics provides molecular testing services for hematological, urogenital, and HPV-associated cancers.

In April, Rutherford, New Jersey-based Cancer Genetics signed an agreement with America's Choice Provider Network to provide access to its cancer diagnostic tests.